HURRICANE CAPITAL ADVISORS LLC’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.11M Buy
+350,000
New +$4.63M 1.24% 13
2025
Q4
– Sell
-164,792
Closed -$3.05M – 706
2025
Q3
$3.05M Sell
164,792
-77,928
-32% -$1.22M 0.75% 19
2025
Q2
$3.88M Buy
242,720
+44,659
+23% +$796K 0.93% 24
2025
Q1
$3.85M Sell
198,061
-47,063
-19% -$991K 1.3% 18
2024
Q4
$5.4M Sell
245,124
-131,114
-35% -$2.52M 1.54% 12
2024
Q3
$6.34M Sell
376,238
-250,026
-40% -$3.71M 2.24% 9
2024
Q2
$7.48M Sell
626,264
-81,000
-11% -$905K 2.61% 7
2024
Q1
$7.84M Buy
707,264
+31,000
+5% +$316K 2.18% 9
2023
Q4
$5.86M Buy
+676,264
New +$5.26M 2.28% 9

Other funds holding CLBT

HURRICANE CAPITAL ADVISORS LLC's CLBT Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC opened a new position in Cellebrite (CLBT) in Q2 2026: 350,000 shares worth $5.11M. The stake represents 1.24% of the portfolio and ranks #13 among its holdings. This is a return to the name: HURRICANE CAPITAL ADVISORS LLC previously reported a position in CLBT as recently as Q3 2025.

HURRICANE CAPITAL ADVISORS LLC first reported a position in CLBT in Q4 2023 and has held it in 9 quarters since. The position peaked at $7.84M in Q1 2024. 202 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 350,000 shares of Cellebrite worth $5.11M as of Q2 2026.
  • Cellebrite was a new HURRICANE CAPITAL ADVISORS LLC position in Q2 2026.
  • Cellebrite made up 1.24% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #13 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Cellebrite in Q4 2023 and has held it in 9 quarters since.
  • HURRICANE CAPITAL ADVISORS LLC's Cellebrite position peaked at $7.84M in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.